PL2293780T3 - Mannitol ulegający rozpadowi w jamie ustnej - Google Patents

Mannitol ulegający rozpadowi w jamie ustnej

Info

Publication number
PL2293780T3
PL2293780T3 PL09772745T PL09772745T PL2293780T3 PL 2293780 T3 PL2293780 T3 PL 2293780T3 PL 09772745 T PL09772745 T PL 09772745T PL 09772745 T PL09772745 T PL 09772745T PL 2293780 T3 PL2293780 T3 PL 2293780T3
Authority
PL
Poland
Prior art keywords
orodispersible
mannitol
orodispersible mannitol
Prior art date
Application number
PL09772745T
Other languages
English (en)
Inventor
Baptiste Boit
Philippe Lefevre
Damien Passe
Original Assignee
Roquette Frères
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Frères filed Critical Roquette Frères
Publication of PL2293780T3 publication Critical patent/PL2293780T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
PL09772745T 2008-07-04 2009-07-02 Mannitol ulegający rozpadowi w jamie ustnej PL2293780T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0854584A FR2933299B1 (fr) 2008-07-04 2008-07-04 Mannitol orodispersible
EP09772745.7A EP2293780B1 (fr) 2008-07-04 2009-07-02 Mannitol orodispersible
PCT/FR2009/051293 WO2010001063A1 (fr) 2008-07-04 2009-07-02 Mannitol orodispersible

Publications (1)

Publication Number Publication Date
PL2293780T3 true PL2293780T3 (pl) 2020-05-18

Family

ID=40379654

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09772745T PL2293780T3 (pl) 2008-07-04 2009-07-02 Mannitol ulegający rozpadowi w jamie ustnej

Country Status (11)

Country Link
US (2) US9839610B2 (pl)
EP (1) EP2293780B1 (pl)
JP (1) JP5753081B2 (pl)
CN (2) CN102065843B (pl)
CA (1) CA2727109C (pl)
ES (1) ES2763578T3 (pl)
FR (1) FR2933299B1 (pl)
MX (1) MX2010014503A (pl)
PL (1) PL2293780T3 (pl)
RU (1) RU2500388C2 (pl)
WO (1) WO2010001063A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010086989A1 (ja) * 2009-01-29 2010-08-05 日東電工株式会社 口腔内フィルム状基剤及び製剤
FR2944971B1 (fr) * 2009-04-30 2012-09-07 Roquette Freres Coagglomerats de mannitol et d'amidon granulaire comprimables et a ecoulement libre
FR2949296B1 (fr) * 2009-09-01 2011-11-18 Roquette Freres Procede de remplacement total ou partiel du talc dans les chewing-gums
JP5751868B2 (ja) 2010-03-30 2015-07-22 日東電工株式会社 フィルム状製剤及びその製造方法
US20130072578A1 (en) 2010-06-01 2013-03-21 Catherine Patricia L. BOGHMANS Orodispersible tablets of erythritol and isomalt
FR2966828B1 (fr) * 2010-11-02 2012-12-28 Roquette Freres Poudre de polysaccharide et de polyol, comprimable et de haute viscosite
JP5841433B2 (ja) 2012-01-11 2016-01-13 日東電工株式会社 口腔内フィルム状基剤及び製剤
CA2916077C (en) * 2015-12-22 2023-06-20 Euro-Pharm International Canada Inc. Nicotine-containing solid oral formulations and uses thereof
EP4395730A1 (en) 2021-08-30 2024-07-10 The Procter & Gamble Company Dissolvable solid structure comprising first and second polymeric structurants
CN120076787A (zh) 2022-10-28 2025-05-30 罗盖特公司 用于配制湿气敏感性活性成分的化合物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6185331A (ja) * 1984-10-04 1986-04-30 Fuji Kagaku Kogyo Kk 直打用賦形薬の製造法
FR2679451B1 (fr) 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
NZ279674A (en) 1994-01-27 1997-02-24 Univ Oklahoma Rapidly dissolving oral dosage form containing a particulate support matrix
US5939091A (en) 1997-05-20 1999-08-17 Warner Lambert Company Method for making fast-melt tablets
TW527195B (en) * 1997-10-09 2003-04-11 Ssp Co Ltd Fast-soluble solid pharmaceutical combinations
JP2000273039A (ja) * 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
ATE283708T1 (de) * 1999-02-15 2004-12-15 Sumitomo Pharma Im mundraum schnellzerfallende tabletten
US6740339B1 (en) * 1999-06-18 2004-05-25 Takeda Chemical Industries, Ltd. Quickly disintegrating solid preparations
DE60036205T2 (de) * 2000-07-27 2008-05-21 Roquette Frères Granulat bestehend aus Stärke und Laktose
US6544552B2 (en) * 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
US20040071772A1 (en) 2001-03-06 2004-04-15 Shoichi Narita Preparations quickly disintegrating in oral cavity
DE10161402A1 (de) * 2001-12-13 2003-06-18 Merck Patent Gmbh Verfahren zur Herstellung von direkt tablettierbarem beta-Mannit
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
ES2199061B1 (es) 2002-06-10 2005-02-16 Laboratorios Vita, S.A. Comprimidos bucodispersables y procedimiento para su obtencion.
US8545881B2 (en) * 2004-04-19 2013-10-01 Eurand Pharmaceuticals, Ltd. Orally disintegrating tablets and methods of manufacture
JP5004236B2 (ja) * 2005-02-09 2012-08-22 キッセイ薬品工業株式会社 口腔内崩壊錠
US8778392B2 (en) * 2007-03-13 2014-07-15 Dainippon Sumitomo Pharma Co., Ltd. Oral disintegrating tablet

Also Published As

Publication number Publication date
CA2727109A1 (fr) 2010-01-07
US9839610B2 (en) 2017-12-12
CN102065843B (zh) 2015-01-21
JP2011526612A (ja) 2011-10-13
US10105314B2 (en) 2018-10-23
US20160331681A1 (en) 2016-11-17
WO2010001063A1 (fr) 2010-01-07
ES2763578T3 (es) 2020-05-29
RU2011103918A (ru) 2012-08-10
CN102065843A (zh) 2011-05-18
EP2293780A1 (fr) 2011-03-16
FR2933299A1 (fr) 2010-01-08
JP5753081B2 (ja) 2015-07-22
US20110111037A1 (en) 2011-05-12
EP2293780B1 (fr) 2019-10-09
CN104382868B (zh) 2018-12-07
MX2010014503A (es) 2011-02-25
FR2933299B1 (fr) 2012-02-03
RU2500388C2 (ru) 2013-12-10
CA2727109C (fr) 2017-11-07
CN104382868A (zh) 2015-03-04

Similar Documents

Publication Publication Date Title
IL209017A0 (en) Structured coauthoring
GB0815435D0 (en) Formulations
GB2459691B (en) Formulations
PL2293780T3 (pl) Mannitol ulegający rozpadowi w jamie ustnej
GB0823269D0 (en) Formulations
GB2463886B (en) Lifts
GB0821789D0 (en) Formulations
ZA201102084B (en) Runflat
EP2307021A4 (en) FORMULATIONS
ZA201101966B (en) Game
GB0814728D0 (en) New combination
GB0917155D0 (en) Demodulator
GB0811100D0 (en) New combination
GB0814729D0 (en) New combination
GB2475215B (en) Game
GB0921378D0 (en) Formulations
GB0916030D0 (en) Formulations
GB0822171D0 (en) Temisartan formulations
GB0815042D0 (en) Inkless
GB0810552D0 (en) Combination
IL192531A0 (en) Watch-bluetooth combination
GB0809185D0 (en) Game
GB0808126D0 (en) Game
GB0806869D0 (en) Game
GB0816139D0 (en) Game